BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9384675)

  • 1. Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy.
    Johnson BJ; Ress SR; Willcox P; Pati BP; Lorgat F; Stead P; Saha R; Lukey P; Laochumroonvorapong P; Corral L
    Cytokines Mol Ther; 1995 Sep; 1(3):185-96. PubMed ID: 9384675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential gene expression in response to adjunctive recombinant human interleukin-2 immunotherapy in multidrug-resistant tuberculosis patients.
    Johnson BJ; Estrada I; Shen Z; Ress S; Willcox P; Colston MJ; Kaplan G
    Infect Immun; 1998 Jun; 66(6):2426-33. PubMed ID: 9596698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis.
    Zhang R; Xi X; Wang C; Pan Y; Ge C; Zhang L; Zhang S; Liu H
    PLoS One; 2018; 13(7):e0201025. PubMed ID: 30024982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Th1 and Th2 type cytokine production in patients with active tuberculosis.
    Handzel ZT; Barak V; Altman Y; Bibi H; Lidgi M; Iancovici-Kidon M; Yassky D; Raz M
    Isr Med Assoc J; 2007 Jun; 9(6):479-83. PubMed ID: 17642401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12.
    Marchant A; Amedei A; Azzurri A; Vekemans J; Benagiano M; Tamburini C; Lienhardt C; Corrah T; McAdam KP; Romagnani S; D'Elios MM; Del Prete G
    Am J Respir Cell Mol Biol; 2001 Feb; 24(2):187-94. PubMed ID: 11159053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cell-mediated immune response after lung resection surgery for MDR-TB patients.
    Park SK; Hong S; Eum SY; Lee IH; Shin DO; Cho JE; Cho S; Cho SN
    Tuberculosis (Edinb); 2011 Jul; 91(4):300-7. PubMed ID: 21514229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients.
    Bourgarit A; Carcelain G; Martinez V; Lascoux C; Delcey V; Gicquel B; Vicaut E; Lagrange PH; Sereni D; Autran B
    AIDS; 2006 Jan; 20(2):F1-7. PubMed ID: 16511406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study.
    Elliott AM; Hurst TJ; Balyeku MN; Quigley MA; Kaleebu P; French N; Biryahwaho B; Whitworth JA; Dockrell HM; Hayes RJ
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):239-47. PubMed ID: 10094326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro levels of cytokines in response to purified protein derivative (PPD) antigen in a population with high prevalence of pulmonary tuberculosis.
    Giampietro F; de Waard JH; Rivas-Santiago B; Enciso-Moreno JA; Salgado A; Araujo Z
    Hum Immunol; 2010 Nov; 71(11):1099-104. PubMed ID: 20650294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased phosphorylation of STAT-1, STAT-4 and cytokine release in MDR-TB patients with primary resistance.
    Kim HJ; Chung DH; Kim MJ; Jang JH; Kim YW; Han SK; Shim YS; Yim JJ
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1071-6. PubMed ID: 18713507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30-kDa antigen in recurrent pulmonary tuberculosis patients.
    Lee JS; Song CH; Kim CH; Kong SJ; Shon MH; Suhr JW; Jung SS; Lim JH; Kim HJ; Park JK; Paik TH; Jo EK
    Med Microbiol Immunol; 2003 May; 192(2):61-9. PubMed ID: 12736818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with multidrug-resistant tuberculosis with low CD4+ T cell counts have impaired Th1 responses.
    McDyer JF; Hackley MN; Walsh TE; Cook JL; Seder RA
    J Immunol; 1997 Jan; 158(1):492-500. PubMed ID: 8977227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placebo.
    Johnson BJ; Bekker LG; Rickman R; Brown S; Lesser M; Ress S; Willcox P; Steyn L; Kaplan G
    Tuber Lung Dis; 1997; 78(3-4):195-203. PubMed ID: 9713652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreaks of mycobacterium tuberculosis MDR strains induce high IL-17 T-cell response in patients with MDR tuberculosis that is closely associated with high antigen load.
    Basile JI; Geffner LJ; Romero MM; Balboa L; Sabio Y García C; Ritacco V; García A; Cuffré M; Abbate E; López B; Barrera L; Ambroggi M; Alemán M; Sasiain MC; de la Barrera SS
    J Infect Dis; 2011 Oct; 204(7):1054-64. PubMed ID: 21881121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy.
    Hirsch CS; Toossi Z; Othieno C; Johnson JL; Schwander SK; Robertson S; Wallis RS; Edmonds K; Okwera A; Mugerwa R; Peters P; Ellner JJ
    J Infect Dis; 1999 Dec; 180(6):2069-73. PubMed ID: 10558973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis.
    Giosuè S; Casarini M; Ameglio F; Zangrilli P; Palla M; Altieri AM; Bisetti A
    Eur Cytokine Netw; 2000 Mar; 11(1):99-104. PubMed ID: 10705306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.